Health and Fitness Health and Fitness
Mon, October 17, 2011
[ Mon, Oct 17th 2011 ] - Market Wire
Enzon Announces Management Change, Forms Special Committee of the Board
[ Mon, Oct 17th 2011 ] - Market Wire
Cubist Pharmaceuticals Appoints Jennifer Jackson as Senior Vice President, Regulatory Affairs
[ Mon, Oct 17th 2011 ] - Market Wire
Medtronic Elects Michael O. Leavitt to the Board of Directors
[ Mon, Oct 17th 2011 ] - Market Wire
OPKO Health to Share in NIH Grant Award
[ Mon, Oct 17th 2011 ] - Market Wire
Tripp Levy PLLC Announces Investigation of Anadys Pharmaceuticals
[ Mon, Oct 17th 2011 ] - Market Wire
TheraBiogen, Inc. Announces Financing Agreement With ECAP Capital to Fund Record Shipments
[ Mon, Oct 17th 2011 ] - Market Wire
Futuremed Announces Timing of Third Quarter 2011 Results &;; Conference Call
[ Mon, Oct 17th 2011 ] - Market Wire
Healthways Takes Its Commitment to Well-Being on .. nual Overnight Ragnar Relay Tennessee Partnership
[ Mon, Oct 17th 2011 ] - Market Wire
Leisureworld Announces October Dividend
[ Mon, Oct 17th 2011 ] - Market Wire
Medtronic Announces 510(k) Clearance for the Aqua .. ined Hemostatic Sealing and Cutting Functionality
[ Mon, Oct 17th 2011 ] - Market Wire
PharmStar Outstanding Common Stock Reduced by 50%
[ Mon, Oct 17th 2011 ] - Market Wire
AdCare Health Systems to Acquire Five Skilled Nursing Facilities in Oklahoma
[ Mon, Oct 17th 2011 ] - Market Wire
DMRJ Amends Implant Sciences' Credit Facility
[ Mon, Oct 17th 2011 ] - Market Wire
Marina Biotech, Inc. Announces a $15 Million Purc .. ase Agreement With Lincoln Park Capital Fund, LLC
[ Mon, Oct 17th 2011 ] - Market Wire
Lpath Initiates Dosing of iSONEP in Second of Two Proof-of-Concept Trials
[ Mon, Oct 17th 2011 ] - Market Wire
Immunovaccine Appoints Wayne Pisano to its Board
[ Mon, Oct 17th 2011 ] - Market Wire
Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested
[ Mon, Oct 17th 2011 ] - Market Wire
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
[ Mon, Oct 17th 2011 ] - Market Wire
CytoSorbents Corporation Launches HemoDefend Puri .. for Blood Transfusion Applications at the AABB Co
Sun, October 16, 2011
[ Sun, Oct 16th 2011 ] - Market Wire
China Medical Technologies Announces the Approval .. Technology Enterprise Status for a Major Subsidia
Sat, October 15, 2011
[ Sat, Oct 15th 2011 ] - Market Wire
The Medicines Company's MDCO-2010 Meets Clinical .. ectives in Patients Undergoing Open-Heart Surgery
Fri, October 14, 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Newly Published Study Highlights Systemic Growth .. g" Market;; DRM Ventures (DRM) and Patient
[ Fri, Oct 14th 2011 ] - Market Wire
Sangamo BioSciences Announces Presentation at the .. ual Newsmakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Par Pharmaceutical Files Declaratory Judgment to .. s to Disseminate Truthful Information Regarding M
[ Fri, Oct 14th 2011 ] - Market Wire
MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Amarillo Biosciences Issues Corporate Update
[ Fri, Oct 14th 2011 ] - Market Wire
Enzo Reports Record Revenues of $102 Million for Fiscal Year 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Greatbatch, Inc. Elects Anthony P. Bihl III to its Board of Directors
[ Fri, Oct 14th 2011 ] - Market Wire
New Data on Tevaa?s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS
[ Fri, Oct 14th 2011 ] - Market Wire
Dynavax to Present at Newsmakers in the Biotech Industry Conference

Dynavax to Present at Newsmakers in the Biotech Industry Conference


Published on 2011-10-14 09:36:03 - Market Wire
  Print publication without navigation


October 14, 2011 12:27 ET

Dynavax to Present at Newsmakers in the Biotech Industry Conference

BERKELEY, CA--(Marketwire - Oct 14, 2011) - Dynavax Technologies Corporation (NASDAQ: [ DVAX ]) announced today that it plans to present at the NewsMakers in the Biotech Industry Conference in New York on Friday, October 21, 2011 at 10:00 a.m. EDT (7:00 a.m. PDT).

Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a corporate overview presentation. To access the live webcast and the subsequent archived recording of the presentation, please log onto Dynavax's website at [ http://investors.dynavax.com/newsevents.cfm ].

About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and superior protection with fewer doses than current licensed vaccines. For more information visit [ www.dynavax.com ].


Contributing Sources